Ultrasound-guided pericapsular nerve group and obturator nerve phenol neurolysis for refractory inpatient hip cancer metastasis pain: a case report

Bone cancer metastasis may produce severe and refractory pain. It is often difficult to manage with systemic analgesics. Chemical neurolysis may be an effective alternative in terminally ill patients. Female terminally ill patient with hip metastasis of gastric cancer in severe pain. Neurolytic ultr...

Full description

Saved in:
Bibliographic Details
Published inBrazilian journal of anesthesiology (Elsevier) Vol. 74; no. 1; p. 744089
Main Authors Pimenta, Marcio V., Nakamura, Amanda T., Ashmawi, Hazem A., Vieira, Joaquim E., dos Santos Fernandes, Hermann
Format Journal Article
LanguageEnglish
Published Brazil Elsevier España S.L.U 01.01.2024
Elsevier
Subjects
Analgesics
Arthralgia
Cancer Pain - drug therapy
Case Reports
Chemical neurolysis
Female
Femoral Nerve
Hip
Humans
Inpatients
Metastasis
Neoplasms
Obturator Nerve
Pain management
Pain, Intractable - drug therapy
Pain, Intractable - etiology
Phenol
Phenols - pharmacology
Regional anesthesia
Ultrasonography, Interventional
Regional anesthesia
Metastasis
Chemical neurolysis
Hip
Pain management
Online AccessGet full text

Cover

More Information
Summary:Bone cancer metastasis may produce severe and refractory pain. It is often difficult to manage with systemic analgesics. Chemical neurolysis may be an effective alternative in terminally ill patients. Female terminally ill patient with hip metastasis of gastric cancer in severe pain. Neurolytic ultrasound-guided blocks of the pericapsular nerve group and obturator nerve were performed with 5% phenol. This led to satisfactory pain relief for 10 days, until the patient's death. This approach may be effective and safe as an analgesic option for refractory hip pain due to metastasis or pathologic fracture in terminally ill patients.
ISSN:0104-0014
0104-0014
2352-2291
DOI:10.1016/j.bjane.2021.02.037